• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTICS PRODUCT ANTI-HIV1+2 REAGENT; IN VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTICS PRODUCT ANTI-HIV1+2 REAGENT; IN VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6801861
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/03/2014
Event Type  malfunction  
Event Description
The customer obtained repeatable, (b)(6) vitros anti-hiv1+2 results from a single patient sample on a vitros 5600 integrated systems when compared to a single (b)(6) result obtained using a non ocd roche hiv combo assay.Biased results of the direction and magnitude observed could lead to inappropriate physician action.It is unknown if the (b)(6) vitros anti-hiv1+2 result was reported outside of the laboratory.There was no report of patient harm as a result of this event.(b)(4).
 
Manufacturer Narrative
Repeatable (b)(6) vitros ahiv 1+2 results were obtained from a patient sample compared to a single (b)(6) result obtained using a non ocd roche hiv combo assy.The event was isolated to a single patient sample.A review of the customer¿s vitros 5600 instrument data logs did not reveal any instrument issue that may have contributed to the event.The vitros ahiv 1+2 assay can only detect the presence of antibody to (b)(6) in a sample.Only a single qualitative (b)(6) roche hiv assay result was provided, and the roche assay is capable of detecting both antibody to (b)(6).However, because of the roche hiv combo method (b)(6) result, it is possible antibody to (b)(6) is present in the sample; therefore ocd will conservatively report this event to regulatory authorities as a (b)(6) vitros ahiv 1+2 event.The customer made no allegation that inappropriate medical action was taken resulting in actual or potential harm to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTICS PRODUCT ANTI-HIV1+2 REAGENT
Type of Device
IN VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key3878131
MDR Text Key4589423
Report Number3007111389-2014-00126
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeMX
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 06/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/04/2014
Device Catalogue Number6801861
Device Lot Number3130
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/19/2014
Initial Date FDA Received06/17/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/04/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-